Target Price | €8.80 |
Price | €2.55 |
Potential |
245.10%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Heidelberg Pharma price target 2025.
The average Heidelberg Pharma target price is €8.80.
This is
245.10%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Heidelberg Pharma to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Heidelberg Pharma stock has an average upside potential 2025 of
245.10%
register free of charge
|
Nov '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 9.86 | 10.00 |
46.73% | 1.42% | |
EBITDA Margin | -270.18% | -210.00% |
182.55% | 22.27% | |
Net Margin | -207.95% | -219.02% |
55.85% | 5.32% |
1 Analyst has issued a sales forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Heidelberg Pharma 2024 . The average Heidelberg Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Nov '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | -0.44 | -0.47 |
16.98% | 6.82% | |
P/E | negative | |
EV/Sales | 10.36 |
1 Analysts have issued a Heidelberg Pharma forecast for earnings per share. The average Heidelberg Pharma <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Heidelberg Pharma stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Heidelberg Pharma...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.